[Federal Register Volume 74, Number 76 (Wednesday, April 22, 2009)]
[Notices]
[Pages 18384-18385]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9155]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-09-0571]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS D-74, Atlanta, GA 30333 or send an e-
mail to <a href="/cdn-cgi/l/email-protection#b9d6d4dbf9daddda97ded6cf"><span class="__cf_email__" data-cfemail="6a0507082a090e09440d051c">[email protected]</span></a>.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Minimum Data Elements (MDEs) for the National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP)--Extension--National Center 
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers 
for Disease Control and Prevention (CDC).

Background and Brief Description

    Many cancer-related deaths in women could be avoided by increased 
utilization of appropriate screening and early detection tests for 
breast and cervical cancer. Mammography is extremely valuable as an 
early detection tool because it can detect breast cancer well before 
the woman can feel the lump, when the cancer is still in an early and 
more treatable stage. Similarly, a substantial proportion of cervical 
cancer-related deaths could be prevented through the detection and 
treatment of precancerous lesions. The Papanicolaou (Pap) test is the 
primary method of detecting both precancerous cervical lesions as well 
as invasive cervical cancer. Mammography and Pap tests are underused by 
women who have no source or no regular source of health care and women 
without health insurance.
    Despite the availability and increased use of effective screening 
and early detection tests for breast and cervical cancers, the American 
Cancer Society (ACS) estimated that 182,460 new cases of breast cancer 
would be diagnosed among women in 2008, and that 40,480 women would die 
of this disease. The ACS also estimated that 11,070 new cases of 
invasive cervical cancer would be diagnosed in 2008, and that 3,870 
women would die of this disease.
    The CDC's National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP) provides screening services to underserved women 
through cooperative agreements with 50 States, the District of 
Columbia, 5 U.S. Territories, and 12 American Indian/Alaska Native 
tribal programs. The program was established in response to the Breast 
and Cervical Cancer Mortality Prevention Act of 1990. Screening 
services include clinical breast examinations, mammograms and Pap 
tests, as well as timely and adequate diagnostic testing for abnormal 
results, and referrals to treatment for cancers detected. Awardees 
collect patient level screening and tracking data to manage the program 
and clinical services. A de-identified subset of data on patient 
demographics, screening tests and outcomes are reported by each awardee 
to CDC twice per year in the Minimum Data Elements (MDE) OMB No. 0920-
0571, exp. 1/31/2010). Burden to respondents was significantly reduced 
in 2008 when the annual requirement to report infrastructure 
information (System for Technical Assistance Reporting, STAR), 
previously associated with collection of MDE information, was 
discontinued.
    CDC plans to request OMB approval to collect MDE information for an 
additional three years. Because awardees already collect and aggregate 
data at the state, territory and tribal level, the additional burden of 
submitting data to CDC will be small. CDC will use the information to 
monitor and evaluate NBCCEDP awardees; improve the availability and 
quality of screening and diagnostic services for underserved women; 
develop outreach strategies for women who are never or rarely screened 
for breast and cervical cancer, and report program results to Congress 
and other legislative authorities. There are no costs to respondents 
other than their time.

[[Page 18385]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                  Number of     Average  burden
             Type of respondents                 Number of      responses per    per  response     Total burden
                                               respondents *      respondent       (in hours)       (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees............................              68                2                4              544
----------------------------------------------------------------------------------------------------------------


    Dated: April 15, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E9-9155 Filed 4-21-09; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>